References
Bostan EE, Borman P, Bodur H, Barca N (2003) Functional disability and quality of life in patients with ankylosing spondylitis. Rheumatol Int 23:121–126
Bodur H, Ataman Ş, Akbulut L et al (2008) Characteristics and medical management of patients with rheumatoid arthritis and ankylosing spondylitis. Clin Rheumatol 27(9):1119–1125
Onen F, Akar S, Birlik M et al (2005) Prevalence of ankylosing spondylitis in Antalya, Turkey. Clin Rheumatol 24(3):212–214
Barkham N, Kong KO, Tennant A et al (2005) The unmet need for anti-tumour necrosis factor therapy in ankylosing spondylitis. Rheumatology 44:1277–1281
Pham T, Landewe R, van der Linden S et al (2006) An international study on starting tumour necrosis factor blocking agents in ankylosing spondylitis. Ann Rheum Dis 65:1620–1625
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Borman, P., Ayhan, F. & Ceceli, E. The inadequate anti-tumour necrosis factor (anti-TNF) therapy in patients with ankylosing spondylitis. Rheumatol Int 30, 1689–1690 (2010). https://doi.org/10.1007/s00296-009-1283-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-009-1283-y